Advantages of Magnesium isoglycyrrhizinate (MgIG) on protecting liver for patients with Allo-HSCT and effect of MgIG on graft-vetsus-host disease (GVHD)
Latest Information Update: 29 Sep 2016
At a glance
- Drugs Isoglycyrrhizinate (Primary)
- Indications Graft-versus-host disease
- Focus Pharmacodynamics
- 29 Sep 2016 New trial record